Disseminated Gonococcal Infection in CA—Dear Colleague letter from CDPH
Disseminated Gonococcal Infection in CA—Dear Colleague letter from CDPH
December 23, 2020: CDPH requests medical providers should reinstate routine screening recommendations for STDs in females <25 years of age, pregnant females, men who have sex with men and individuals with HIV. Providers should increase their clinical suspicion for DGI in patients with joint pain and undertake the following additional actions.
The California Department of Public Health (CDPH) has received increasing reports of disseminated gonococcal infection (DGI), a severe complication of untreated gonorrhea. Dr. Laura Quilter and Dr. Eric Tang discuss DGI epidemiology, clinical presentation, and management, and review California’s recent DGI investigation and what clinicians can do to help.
Drs. Quilter and Tang cover the following learning objectives for this webinar:
Describe the epidemiology of uncomplicated gonorrhea and DGI
Recognize the clinical manifestations of DGI and increase clinical suspicion for DGI in patients with joint pain
Demonstrate how to diagnose, manage, and treat DGI
Report all laboratory-confirmed and clinically-suspected cases of DGI to public health
Prioritize routine screening, testing, and treatment of STDs among high-risk patients
STD Clinical Consultation Network App
STD Clinical Consultation Network App
STD Clinical Toolbox: A free app for medical professionals nationwide. From the National Network of STD Clinical Prevention Training Centers.
Hepatitis C Online is a free educational website from the University of Washington National Hepatitis Training Center. It addresses the diagnosis, monitoring, and management of hepatitis C virus infection. Free CME credit and CNE/CE contact hours are offered. Pharmacology CE for advanced practice nurses is also available for many activities.
An overview of and frequently asked questions about emergency contraception (EC). EC represents a “last chance” to prevent unintended pregnancy. Categories of EC are emergency contraceptive pills (ECPs), including ulipristal acetate (UPA) and levonorgestrel (LNG) and the copper intrauterine device (IUD).
Holding an IUD birth control copper coil device in hand, used for contraception –
National STD Curriculum: Genital Herpes Simplex Virus
National STD Curriculum: Genital Herpes Simplex Virus
The Herpes Simplex Virus (HSV) STD Module is a web-based training course designed to guide clinicians in the diagnosis, treatment, and prevention of genital herpes infections. CNE/CME credits are available.
Home
Training Implementing the 2019 ASCCP Risk-Based Management Guidelines for Abnormal Cervical Cancer Screening Tests in Your Practice
Implementing the 2019 ASCCP Risk-Based Management Guidelines for Abnormal Cervical Cancer Screening Tests in Your Practice
July 23, 2020
The long-awaited new ASCCP Management Guideline App is now available, as well as the print version of the 2019 Guidelines. The new guidelines are streamlined for ease of use and can be significantly more individualized than the 2012 guidance by integrating information about an individual’s previous screening test and biopsy results, and personal factors such as age and immunosuppression. The guidelines now provide recommended follow up for all 3 available cervical screening strategies.
The following topics are covered in detail:
The rationale used in developing the Guidelines
How various abnormalities should be managed
Interactive demonstrations of how to use the app
Specific considerations for the application of Family PACT benefits, including coding and billing
Learning objectives: At the end of this session, the learner will be able to:
Describe the risk-based paradigm for managing abnormal cervical cancer screening test results.
Explain how risk-thresholds guide the clinical actions of immediate treatment, colposcopy, and short-interval follow up.
Demonstrate use of the ASCCP app to apply the new guidelines to patient care.